Safety-Stock: Predicting the demand for supplies in Brazilian hospitals during the COVID-19 pandemic.

Many challenges lie ahead when dealing with COVID-19, not only related to the acceleration of the pandemic, but also to the prediction of personal protective equipment sets consumption to accommodate the explosive demand. Due to this situation of uncertainty, hospital administration encourages the excess stock of these materials, over-stocking products in some hospitals, and provoking shortages in others. The number of available personal protective equipment sets is one of the three main factors that limit the number of patients at a hospital, as well as the number of available beds and the number of professionals per shift. In this scenario, we developed an easy-to-use expert system to predict the demand for personal protective equipment sets in hospitals during the COVID-19 pandemic, which can be updated in real-time for short term planning. For this system, we propose a naive statistical modeling which combines historical data of the consumption of personal protective equipment sets by hospitals, current protocols for their uses and epidemiological data related to the disease, to build predictive models for the demand for personal protective equipment in Brazilian hospitals during the pandemic. We then embed this modeling in the free Safety-Stock system, which provides useful information for the hospital, especially the safety-stock level and the prediction of consumption/demand for each personal protective equipment set over time. Considering our predictions, a hospital may have its needs related to specific personal protective equipment sets estimated, taking into account its historical stock levels and possible scheduled purchases. The tool allows for adopting strategies to control and keep the stock at safety levels to the demand, mitigating the risk of stock-out. As a direct consequence, it also enables the interchange and cooperation between hospitals, aiming to maximize the availability of equipment during the pandemic.

Analysis of antioxidant, cytotoxic and mutagenic potential of Agave sisalana Perrine extracts using Vero cells, human lymphocytes and mice polychromatic erythrocytes.

Brazilian Northeast is the world's largest producer of Agave sisalana Perrine for the supply of the sisal fiber. About 95% of plant biomass, which comprise the mucilage and sisal juice, is considered a waste residual is discarded in the soil. However, the sisal juice is rich in steroidal saponins, which exhibits different pharmacological properties. Despite this, natural products are not necessarily safe. Based on this, this study analyzed the antioxidant, cytotoxic and mutagenic potential of three extracts derived from acid hydrolysis (AHAS), dried precipitate (DPAS) and hexanic of A. sisalana (HAS). These analyses were performed by in vitro and in vivo methods, using Vero cells, human lymphocytes and mice. Results showed that AHAS 50 and 100 can be considered a useful antineoplastic candidate due to their antioxidant and cytotoxic activity, with no genotoxic/clastogenic potential in Vero cells and mice. Although the comet assay in human lymphocytes has showed that the AHAS 25, AHAS 50 and AHAS 100 can lead to DNA breaks, these extracts did not promote DNA damages in mice bone marrow. Considering the different mutagenic responses obtained with the different methods employed, this study suggest that the metabolizing pathways can produce by-products harmful to health. For this reason, it is mandatory to analyze the mutagenic potential by both in vitro and in vivo techniques, using cells derived from different species and origins.

Analysis of antioxidant, cytotoxic and mutagenic potential of Agave sisalana Perrine extracts using Vero cells, human lymphocytes and mice polychromatic erythrocytes

Brazilian Northeast is the world’s largest producer of Agave sisalana Perrine for the supply of the sisal fiber. About 95% of plant biomass, which comprise the mucilage and sisal juice, is considered a waste residual is discarded in the soil. However, the sisal juice is rich in steroidal saponins, which exhibits different pharmacological properties. Despite this, natural products are not necessarily safe. Based on this, this study analyzed the antioxidant, cytotoxic and mutagenic potential of three extracts derived from acid hydrolysis (AHAS), dried precipitate (DPAS) and hexanic of A. sisalana (HAS). These analyses were performed by in vitro and in vivo methods, using Vero cells, human lymphocytes and mice. Results showed that AHAS 50 and 100 can be considered a useful antineoplastic candidate due to their antioxidant and cytotoxic activity, with no genotoxic/clastogenic potential in Vero cells and mice. Although the comet assay in human lymphocytes has showed that the AHAS 25, AHAS 50 and AHAS 100 can lead to DNA breaks, these extracts did not promote DNA damages in mice bone marrow. Considering the different mutagenic responses obtained with the different methods employed, this study suggest that the metabolizing pathways can produce by-products harmful to health. For this reason, it is mandatory to analyze the mutagenic potential by both in vitro and in vivo techniques, using cells derived from different species and origins.